1. Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis
- Author
-
Sabrina Hoa, Sasha Bernatsky, Murray Baron, Susanna Proudman, Wendy Stevens, Joanne Sahhar, Mianbo Wang, Russell J. Steele, Mandana Nikpour, Marie Hudson, M. Baron, M. Hudson, G. Gyger, S. Hoa, J. Pope, M. Larché, N. Khalidi, A. Masetto, E. Sutton, T.S. Rodriguez-Reyna, N. Maltez, C. Thorne, P.R. Fortin, A. Ikic, D. Robinson, N. Jones, S. LeClercq, J.-P. Mathieu, P. Docherty, D. Smith, M. Fritzler, L. Croyle, J. de Jager, N. Ferdowsi, C. Hill, R. Laurent, S. Lester, G. Major, K. Morrisroe, P. Nash, G. Ngian, M. Nikpour, S. Proudman, M. Rischmueller, J. Roddy, J. Sahhar, L. Schrieber, W. Stevens, G. Strickland, A. Sturgess, V. Thakkar, K. Tymms, J. Walker, P. Youseff, and J. Zochling
- Subjects
Immunosuppression Therapy ,Male ,Risk ,Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Scleroderma, Systemic ,business.industry ,Interstitial lung disease ,Middle Aged ,Critical Care and Intensive Care Medicine ,medicine.disease ,Internal medicine ,medicine ,Humans ,Female ,Observational study ,Lung Diseases, Interstitial ,Cardiology and Cardiovascular Medicine ,business - Published
- 2021
- Full Text
- View/download PDF